Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-β1 regulator and activating the Nrf2 signaling pathway
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 256, 117966
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31370079)
This publication has 24 references indexed in Scilit:
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013
- Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell lineChinese Journal of Integrative Medicine, 2013
- Over-production of nitric oxide by oxidative stress-induced activation of the TGF-β1/PI3K/Akt pathway in mesangial cells cultured in high glucoseActa Pharmacologica Sinica, 2013
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expressionCytokine, 2013
- Heterogeneous Nuclear Ribonucleoprotein F Suppresses Angiotensinogen Gene Expression and Attenuates Hypertension and Kidney Injury in Diabetic MiceDiabetes, 2012
- Nrf2 Activators as Attractive Therapeutics for Diabetic NephropathyDiabetes, 2011
- Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cellsCellular Signalling, 2011
- Oxidative stress and diabetes mellitusClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Oxidative stress in early diabetic nephropathy: fueling the fireNature Reviews Endocrinology, 2010
- Radical approach to diabetic nephropathyKidney International, 2007